Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
MetadataShow full item record
Whyte , C S , Morrow , G B , Mitchell , J L , Chowdary , P & Mutch , N J 2020 , ' Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19 ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 7 , pp. 1548-1555 . https://doi.org/10.1111/jth.14872
© 2020 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/
Showing items related by title, author, creator and subject.
Polyphosphate co-localizes with factor XII on plateletbound fibrin and augments its plasminogen activator activity Mitchell, Joanne L; Lionikiene, Ausra S.; Georgiev, Georgi; Klemmer, Anja; Brain, Chelsea; Kim, Paul Y; Mutch, Nicola J. (2016-12-15)
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi Whyte, Claire S.; Mostefai, Hadj Ahmed.; Baeten, Kim M.; Lucking, Andrew J.; Newby, David E.; Booth, Nuala A.; Mutch, Nicola J. (2021-02-20)
Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery? Schultz-Swarthfigure, Chase T.; McCall, Philip; Docking, Robert; Galley, Helen; Shelley, Benjamin (2021-02-28)